Literature DB >> 6208629

Metabolism of sodium pentosan polysulphate in man--catabolism of iodinated derivatives.

I R MacGregor, J Dawes, L Paton, D S Pepper, C V Prowse, M Smith.   

Abstract

An iodinated derivative of the heparin analogue SP54 has been prepared and used in conjunction with unlabelled SP54 to study the catabolism and organ distribution of this potential antithrombotic agent in healthy human volunteers. As observed previously with 125I-heparin, we found that the 125I-SP54 was rapidly cleared from the circulation, returning later in a desulphated form. Organ distribution studies with 123I-SP54 suggested that the liver and spleen were major sites of desulphation. Gel filtration and Polybrene binding showed the presence of sulphated macromolecular SP54 and desulphated macromolecular and depolymerised SP54 in post-injection urines. No depolymerised material was present in plasma suggesting depolymerisation occurs in the kidney.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208629

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Desulphation of dextran sulphate during kidney ultrafiltration.

Authors:  W D Comper; M Tay; X Wells; J Dawes
Journal:  Biochem J       Date:  1994-01-01       Impact factor: 3.857

2.  Activation of the high affinity nerve growth factor receptor by two polyanionic chemotherapeutic agents: role in drug induced neurotoxicity.

Authors:  J S Gill; A J Windebank
Journal:  J Neurooncol       Date:  1998-10       Impact factor: 4.130

Review 3.  Glycosaminoglycans and other sulphated polysaccharides in calculogenesis of urinary stones.

Authors:  E R Boevé; L C Cao; C F Verkoelen; J C Romijn; W C de Bruijn; F H Schröder
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

4.  Phase I trial of pentosan polysulfate.

Authors:  S M Swain; B Parker; A Wellstein; M E Lippman; C Steakley; R DeLap
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

Review 5.  Prion diseases: immunotargets and therapy.

Authors:  Jennifer T Burchell; Peter K Panegyres
Journal:  Immunotargets Ther       Date:  2016-06-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.